Mitochondrial Quality Regulation Genes as Prognostic Markers in Hepatocellular Carcinoma: Tumor Microenvironment, Therapeutic Response, and Drug Sensitivity Analysis
A robust 4‐MQRG signature comprising ANXA10, BAMBI, AKR1B15, and SPINK1 was established, which revealed that patients classified as high risk had significantly shorter overall survival compared to their low‐risk counterparts, thus offering valuable biomarker support for personalized therapeutic approaches in HCC.